Where there's a WiL, there's a way
An International alliance dedicated to the promotion
of leadership of female lymphoma clinicians and researchers.
WiLing Wednesdays
SERIES 3 - APRIL/MAY 2021
WiLing Wednesdays live webinar tutorial series
SERIES 3 – T-CELL LYMPHOMA
Wednesdays April 7, 14, 21 & 28, May 5, 2021
· Join WiL around the world as we host our third live tutorial series presenting and discussing challenging aspects of contemporary management of lymphoma.
· Series 3 will focus on T-Cell Lymphoma with sessions presented by global leading and emerging WiL.
· Sessions on Zoom are free and open to clinicians, researchers and educators in lymphoma and associated fields.
· Registration for each session via registration links below
or via email invitation from wil@snowdome.org.au
· Session times shown in local time after registration.
UTC - Universal Time Coordinated. www.timeanddate.com
· All five sessions will be recorded and available after each session
SESSION 1 - Wednesday April 7, 2021
· Dr Laurence De Leval – Centre Hospitalier Universitaire Vaudois, SWITZERLAND
UPDATE ON T-CELL LYMPHOMA: HEMPATH REVIEW
&
· Dr Kerry Savage – BC Cancer, Vancouver CANADA
PRIMARY THERAPY OF COMMON PERIPHERAL T-CELL LYMPHOMA
RECORDING LINK:
SESSION 2 - Wednesday April 14, 2021
· A/Prof Siok-Bian Ng – National University of SINGAPORE
HEMPATH REVIEW OF T-CELL LYMPHOMAS COMMON IN ASIA
&
· Dr Yu Qin Song – Peking University Cancer Centre, Beijing CHINA
FRONTLINE & SALVAGE THERAPIES FOR T-CELL LYMPHOMAS COMMON IN ASIA
RECORDING LINK:
Session 3 - Wednesday April 21, 2021
Barbara Pro MD – Northwestern Medicine, Chicago USA
TREATMENT & OUTCOME FOR RELAPSED T-CELL LYMPHOMAS
&
· Neha Mehta-Shah MD – Washington University School of Medicine, St Louis USA
USE OF AUTOLOGOUS & ALLOGENIC TRANSPLANT FOR T-CELL LYMPHOMAS
RECORDING LINK
SESSION 4 - Wednesday April 28, 2021
· Jasmine M. Zain MD – City of Hope CCC, Los Angeles, USA
NEWER THERAPIES & CLINICAL TRIALS FOR T-CELL LYMPHOMAS
&
· Julie Vose MD – University of Nebraska Medical Center, Omaha USA
Jasmine Zain MD – City of Hope CCC, Los Angeles, USA
Jia Ruan MD – Weill Cornell Medicine, New York USA
CASE STUDIES OF T-CELL LYMPHOMAS
RECORDING LINK
SESSION 5 - Wednesday. May 5, 2021
CAREER DEVELOPMENT: INTERVIEWS ON PERSONAL AND CAREER CHOICES
· Sonali Smith MD – UChicago Medicine, Chicago USA
Interviewed by Julie Vose MD - University of Nebraska Medical Center, Omaha USA
&
· Prof. Judith Trotman – Concord Repatriation General Hospital, Sydney AUSTRALIA
Interviewed by Carrie Thompson MD - Mayo Clinic, Rochester MN USA
RECORDING LINK
* * * * *
CLICK HERE TO ACCESS THE RECORDINGS OF SERIES 2
ON HODGKIN LYMPHOMA (January/February 2021)
WiLing Wednesdays - Series 2 - Webinar recordings
Featured WiL
DR CAMILLE GOLFIER
Dr Camille Golfier is an MD working in Lyon Sud Hospital, Lyon, France. She is an expert on lymphoid malignancies.
Student of well-known French haematologist, Professor Gilles Salles (MD, PhD, Lyon, France), Camille completed her medical degree at Lyon University and her physician training in Dijon and Lyon Sud Hospitals.
Aligned with comprehensive care, Camille gained a palliative care degree during her training. She also completed a Masters 2 degree in Science working on epigenetics in T-cell lymphoma with Professor Bachy (MD, PhD, Lyon, France).
Camille is currently involved in a number of clinical trials in lymphoid neoplasms as a member of the independent clinical lymphoma research network - The Lymphoma Study Association (LYSA).